MSA - MULTIPLE SYSTEM ATROPHY
Clinical trials for MSA - MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MSA - MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MSA - MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for MSA patients suffering from severe dizziness
Symptom relief OngoingThis study tests a drug called ampreloxetine in about 100 adults with multiple system atrophy (MSA) who experience dizziness and fainting due to low blood pressure when standing. Participants first receive the drug for 20 weeks, then some are switched to placebo to see if symptom…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief
Last updated Jun 16, 2026 12:49 UTC
-
Nurse-Led video care may ease daily life for rare Parkinson's forms
Symptom relief OngoingThis study tests whether a home-based telenursing program, led by a specialist nurse, can improve quality of life and reduce complications like falls for people with atypical parkinsonism (MSA or PSP). About 164 participants will receive proactive and reactive remote monitoring a…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated Jun 11, 2026 12:11 UTC
-
Mayo clinic launches major brain disease tracking study
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to learn more about diseases that affect the brain, such as Parkinson's disease and different types of dementia. Researchers will follow 500 adults with symptoms of these conditions over time, using brain scans and genetic tests to see how the diseases progress. T…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 17, 2026 02:57 UTC